2763 Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC). (September 2015) - Seifert, H.; Georgiou, A.; Alexander, H.; Bodla, S.; Kaye, S.; Nobbenhuis, M.; Gore, M.; Banerjee, S.